Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/2005
12/29/2005US20050288263 2-(&agr;-Hydroxypently) benzoate and its preparation and use
12/29/2005US20050288262 such as 3,10-Dibenzyloxyminocycline, used to treat bacterial infections and neoplasms, as well as blocking tetracycline efflux and modulation of gene expression
12/29/2005US20050288254 Treating sepsis or septic shock by administering 1-stearoyl, 1-palmitoyl-, 1-myristoyl- lysophosphatidylcholine, or 1-oleoyllysophosphatidylcholine or sphingosylphosphorylcholine.
12/29/2005US20050288248 Polypeptide; polyethylene glycolylated polypeptide; antidiabetic agents; side effect reduction
12/29/2005US20050288237 Novel derivative of flavone c-glycoside and composition containing the same
12/29/2005US20050288235 Sodium chloride; dextran, carboxymethyl starch, sodium alginate, pentahydroxyethyl starch, gelatin derivatives or pectin; NaHCO3, KCl, MgSO4, CaCl, calcium gluconate, calcium lactate, sodium lactate, and/or Tris buffer; total Na ion does not exceed equivalent concentration of 6.9% (w/v); traumatic shock
12/29/2005US20050288232 As prodrug of enalaprilat, which is a medicine useful for preventing or treating circulatory diseases such as hypertension, cardiac diseases, nephritis, and apoplexy, patches; 1-[N-[(1S)-1-Carboxy-3-phenylpropyl]-L-alanyl]-L-proline 2-hydroxyethyl ester
12/29/2005US20050288225 Modulators of intracellular inflammation, cell death and cell survival pathways
12/29/2005US20050288222 Methods for enhancing the bioavailability of a drug
12/29/2005US20050288220 Erythropoietin with high specific activity
12/29/2005US20050288219 Osteoprotegerin in milk
12/29/2005US20050288216 Novel transformed cell, method of screening antiaging agent and antiaging agents
12/29/2005US20050288211 Chemokine inhibitors; for treatment of gout; for inhibiting migration of neutrophils involved in pathogenesis
12/29/2005US20050287617 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
12/29/2005US20050287605 Caspase 3 inhibitors
12/29/2005US20050287581 Gene sequence of alpha(1,3)galactosyltransferase
12/29/2005US20050287546 Novel proteases
12/29/2005US20050287529 Flea and tick octopamine receptor nucleic acid molecules, proteins and thereof
12/29/2005US20050287157 Dry formulation for transcutaneous immunization
12/29/2005US20050287144 For the modulation of signal activities controlled by NF-kappa B-inducing kinase (NIK); cancer , rheumatoid arthritis, osteoarthritis, inflammatory bowel disease, asthma, cardiac infarct, Alzheimer's disease, or atherosclerosis
12/29/2005US20050287139 Wound healing
12/29/2005US20050287079 Combinations of formoterol and fluticasone propionate for asthma
12/29/2005DE19748040B4 Carbonsäurederivate, Verfahren zu ihrer Herstellung und pharmazeutische Präparate, die diese Verbindungen enthalten Carboxylic acid derivatives, processes for their preparation and pharmaceutical preparations containing these compounds
12/29/2005DE102004045187A1 Wirkstoff, der in der Lage ist, die Überführung von inaktivem TGFb-latent in aktiven TGFb zu induzieren Agent that is capable of inducing the conversion of inactive latent TGFb-in active TGFb
12/29/2005CA2569729A1 Peptidomimetic inhibitors of retroviral proteases and their use as antivirals
12/29/2005CA2568601A1 Peptide-based compounds
12/28/2005EP1609864A2 Use of neuronal apoptosis inhibitor protein (NAIP)
12/28/2005EP1609863A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/28/2005EP1609803A1 Modified antibody against cd22 and utilization thereof
12/28/2005EP1609799A1 Heteroaryl 5-thio-beta-d-glucopyranoside derivatives and remedies for diabetes containing the same
12/28/2005EP1609798A1 Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof
12/28/2005EP1609790A2 Benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists
12/28/2005EP1609788A1 Novel crystal of fluorobenzamide derivative
12/28/2005EP1609781A1 Optical resolution of (1-benzyl-4-methylpiperidin-3-yl)-methylamine
12/28/2005EP1609472A1 Therapeutic agent for hemorrhoidal disease
12/28/2005EP1609362A2 Non-systemic control of parasites
12/28/2005EP1608651A1 Protein kinase inhibitors
12/28/2005EP1527076B1 Dihydro-dibenzo[b,e]oxepine based selective estrogen receptor modulators, compositions and methods
12/28/2005EP1497288B1 Novel ester hydroxy-substituted nitrogen heterocycles as antagonists of the muscarinic m3 receptor, methods for the production thereof, and use thereof as a medicament
12/28/2005EP1490013A4 Methods, compositions, and kits for enhancing oligonucleotide-mediated nucleic acid sequence alteration using compositions comprising a histone deacetylase inhibitor, lambda phage beta protein, or hydroxyurea
12/28/2005EP1470124B1 2-(PYRIDIN-2-YLAMINO)-PYRIDO 2,3-d]PYRIMIDIN-7-ONES
12/28/2005EP1461318B9 Tetrahydroquinoline analogues as muscarinic agonists
12/28/2005EP1432450B1 Therapeutically useful triethyleneglycol cholesteryl oligonucleotides
12/28/2005EP1427403B1 Valproic acid for the treatment of breast cancer, colon cancer, head and neck cancer, small cell lung carcinoma and cancer of the blood cells in combination with irradiation
12/28/2005EP1414438B1 Antineoplastic combinations
12/28/2005EP1385512B1 Use of pyridoindolone derivatives for preparing anticancer medicines
12/28/2005EP1373241B1 Method for producing optically active dihydropyrones
12/28/2005EP1367060B1 Glucopyranosyloxybenzylbenzene derivatives and medicinal use thereof
12/28/2005EP1355650B1 Combination of active ingredients containing alfuzosine and apomorphine
12/28/2005EP1326597B1 Use of kcnq potassium channel agonists for the manufacture of a medicament for modulating bladder function
12/28/2005EP1317489B1 A mixture of non-sulfated fucose-based oligosaccharides, a cosmetic or pharmaceutical composition comprising said mixture and its use in cosmetics or pharmacy
12/28/2005EP1299352B1 Compounds to treat alzheimer's disease
12/28/2005EP1274454B1 Methods and compositions for eliciting an immune response
12/28/2005EP1257276B1 Antiviral azaindole derivatives
12/28/2005EP1251843B1 Compositions for delivery of a cortisol antagonist
12/28/2005EP1235565B1 Use of 5ht 3 agonists for relaxing the fundus
12/28/2005EP1224183B1 Heterocyclic sodium/proton exchange inhibitors and method
12/28/2005EP1223170B1 Pyrimidine-5-carboxamide compounds, process for producing the same and use thereof
12/28/2005EP1206242B1 Use of bacterial extracts of the pseudomonadaceae family as cosmetic agents
12/28/2005EP1173433B1 Cyanopyrroles as progesterone receptor agonists
12/28/2005EP1140930B1 DIBENZO a,g]QUINOLIZINIUM DERIVATIVES AND THE SALTS THEREOF
12/28/2005EP1135158B1 Enhanced vaccines based on chimeric immunoglobulin e peptides
12/28/2005EP1124810B9 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents
12/28/2005EP1085909B1 A complex of alpha-fetoprotein (AFP) and a polyunsaturated fatty acid derivative for the treatment of immune deficiencies
12/28/2005EP1084125B1 Condensed thienopyrimidines with phosphodiesterase-v inhibiting action
12/28/2005EP1082128B1 Lysine containing peptides for treatment of heart disease
12/28/2005EP1073683B1 G-csf receptor agonist antibodies and screening method therefor
12/28/2005EP1066033B1 Smilagenin and anzurogenin-d for the treatment of alzheimer's disease
12/28/2005EP1024802B1 Cannabinol-11-oic acid derivatives useful as antiinflammatory agents and analgesics
12/28/2005EP0994093B1 Polyhydroxyphenol derivatives and preventive and therapeutic agents for bone and cartilage diseases containing the same
12/28/2005EP0920315B1 Treatment of upper airway allergic responses with a combination of histamine receptor antagonists
12/28/2005EP0918514B1 Triaryl methane compounds for the treatment of cancer, actinic keratosis and kaposi's sarcoma
12/28/2005EP0876387B1 Use of roxithromycin for the preparation of a medicament for improving the biological and antiviral activity of protease inhibitors
12/28/2005EP0742834B9 Method of preparing a viral vector of at least 20kb by intermolecular recombination in a procaryotic cell
12/28/2005EP0716609B1 Methods and compositions for stimulating and inhibiting tgf-beta activity
12/28/2005CN1714151A Novel glutamate receptor modulatory proteins and nucleic acid molecules and uses therefor
12/28/2005CN1714116A Modified bio-related substance, process for producing the same, and intermediate
12/28/2005CN1714096A Mmp inhibitors
12/28/2005CN1714084A Pyrimidine-2,4,6-trione metalloproteinase inhibitors
12/28/2005CN1714077A 2-,3-4- or 5-substituted-n1-(benzensulfonyl)indoles and their use in therapy.
12/28/2005CN1713922A Combinations of (a) an ATP-competitive inhibitor of c-acl kinase activity with (b) two or more other antineoplastic agents
12/28/2005CN1713918A Muscle building preparation
12/28/2005CN1713900A Use of norepinephrine reuptake inhibitors for the treatment of cognitive failure
12/28/2005CN1713895A Increased-dosage nelfinavir tablet and method of making same
12/28/2005CN1233649C Compound Bajisu A and its preparation and use
12/28/2005CN1233415C CD26/DPP IV application in preparation of medicine for treating and/or diagnosing disease
12/28/2005CN1233376C Anti-fatigue beverage
12/28/2005CN1233374C Chemical for promoting growth of hairs, blackening hair and preventing sinility
12/28/2005CN1233348C Black boned chicken active capsule
12/28/2005CN1233333C Process for preparing Tibetan medicines
12/28/2005CN1233328C Cell growth regulating factor K and its preparation process
12/28/2005CN1233325C Drug for treatment of osteonecrosis and for management of patients at risk of steonecrosis
12/28/2005CN1233324C Use of composition of intraocular pressure reducing agent
12/27/2005US6979747 Antioxidants, preparation processes and their uses
12/27/2005US6979694 Drugs such as (5-(((2,4,6-Trimethylphenyl)amino)carbonyl)-4-methyl-2-thiazolyl)carbamic acid, 1,1-dimethylethyl ester, used as enzyme inhibitors, for prohylaxis of inflammatory bowel disease; modulation of immunology
12/27/2005US6979692 Triamide-substituted heterobicyclic compounds
12/27/2005US6979691 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
12/27/2005US6979690 Oxo or oxy-pyridine compounds as 5-HT4 receptor modulators
12/27/2005US6979683 Polymerase enzyme inhibitors
12/27/2005US6979447 Immunomodulation and effect on cell processes relating to serotonin family receptors
1 ... 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 ... 1564